SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-003529
Filing Date
2022-05-16
Accepted
2022-05-16 16:58:19
Documents
60
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q thct_10q.htm   iXBRL 10-Q 705313
2 CERTIFICATION thct_ex311.htm EX-31.1 9272
3 CERTIFICATION thct_ex312.htm EX-31.2 10584
4 CERTIFICATION thct_ex321.htm EX-32.1 3652
5 CERTIFICATION thct_ex322.htm EX-32.2 3680
  Complete submission text file 0001477932-22-003529.txt   3569923

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA thct-20211031.xsd EX-101.SCH 41984
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20211031_lab.xml EX-101.LAB 215517
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20211031_cal.xml EX-101.CAL 35108
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20211031_pre.xml EX-101.PRE 189099
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20211031_def.xml EX-101.DEF 117486
54 EXTRACTED XBRL INSTANCE DOCUMENT thct_10q_htm.xml XML 511320
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

IRS No.: 260164981 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55994 | Film No.: 22930474
SIC: 3523 Farm Machinery & Equipment